TobaccoIntelligence

Regulatory & market intelligence for alternative tobacco & nicotine products

Regulatory briefing

US FDA grants modified risk orders to PMI’s IQOS and Marlboro HeatSticks

Written by || 7th July 2020 || Regulatory briefing | Heated tobacco | IQOS | North America United States

The US Food and Drug Administration (FDA) has granted Philip Morris International (PMI) modified risk tobacco product (MRTP) status for IQOS and its associated HeatSticks ...

Restricted content. Do you want to read more?

Read our latest free content

‘Utopian’ – but is a global consensus on smoke-free alternatives a realistic goal?
What e-cigarette process tells us about the US FDA’s thinking on tobacco
US International Trade Commission bans imports of PMI’s Iqos HeatSticks
Is Big Tobacco growing environmentally friendly – or is it merely greenwash?
Survey backs EU-wide tax harmony on heated tobacco and oral nicotine
False beliefs about tobacco alternatives are themselves a public health problem

Featured topic

The shift of the Mexican government toward allowing the sale of these smoke-free devices

A step forward on heated tobacco taken by the US Food and Drug Administration (FDA)

Blog| Regulatory Briefing | Heated tobacco

Sign up to our newsletter

By signing up you agree to our Terms and Conditions